Managing Director And Founder
CurrentI started C2C twenty-four years ago to help computer scientists, professors, and graduate students start technology companies based on their research.We are an active partner at the earliest stage (often before there is a company). In addition to providing capital, we help founders close initial customers, find product-market fit, license technology from their university, recruit a team, and turn ideas and products into successful businesses.We invite potential partners to check us out by contacting anyone with whom we have done business in the past. You’ll find that we are unusual: we prefer academic founders who lead their companies as full-time members of the management team; we are very patient capital (no pressure for an “exit”); our own management structure is predictable for decades to come.We focus on companies that use AI or improve AI infrastructure. A small number of companies are formed every year with technologies that change the world. We aspire to partner with those companies and their founders at the earliest stage, serving as a trusted source of capital and advice.C2C was the first investor in companies that have been acquired for more than $2 billion in cash.C2C companies have raised more than $70 million in seed-stage venture capital and $525 million in follow-on capital from leading venture firms, including Accel Partners, Andreessen Horowitz, Bezos Expeditions, Founders Fund, Index Ventures, Kleiner Perkins, Khosla Ventures, New Enterprise Associates, Union Square Ventures.We were among the first VC investors in Stack Overflow (started in 2010, acquired in 2021 by Prosus for $1.8 billion in cash), Sentry (started at Disqus in 2013), Cellular Research, Inc. (started at Stanford in 2013, acquired in 2015 by Becton, Dickinson for $120 million in cash), BioImagene (started at UCLA in 2003, acquired in 2010 by Roche for $100 million in cash), and other companies.
